國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Rare kidney tumorscomprehensive mult...

Malouf, Gabriel G.

Rare kidney tumorscomprehensive multidisciplinary management and emerging Therapies /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Rare kidney tumorsedited by Gabriel G. Malouf, Nizar M. Tannir.
其他題名:	comprehensive multidisciplinary management and emerging Therapies /
其他作者:	Malouf, Gabriel G.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	ix, 128 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	KidneysCancer.
電子資源:	https://doi.org/10.1007/978-3-319-96989-3
ISBN:	9783319969893$q(electronic bk.)

Rare kidney tumorscomprehensive multidisciplinary management and emerging Therapies /
Rare kidney tumorscomprehensive multidisciplinary management and emerging Therapies /[electronic resource] :edited by Gabriel G. Malouf, Nizar M. Tannir. - Cham :Springer International Publishing :2019. - ix, 128 p. :ill., digital ;24 cm.

Introduction -- Hereditary RCC Syndromes -- Wilms Tumor -- Renal Cell Carcinomas in Children -- Chromophobe Renal Cell Carcinomas -- Papillary Renal Cell Carcinoma -- Renal Medullary Carcinomas -- Collecting Duct Carcinomas -- Translocation Renal Cell Carcinomas -- Angiomylipoma -- Sarcomatoid and Rhabdoid Renal Cell Carcinoma -- Conclusion.

This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist. Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors.

ISBN: 9783319969893$q(electronic bk.)

Standard No.: 10.1007/978-3-319-96989-3doiSubjects--Topical Terms:

560142
Kidneys
--Cancer.

LC Class. No.: RC280.K5 / R374 2019

Dewey Class. No.: 616.99461

Rare kidney tumorscomprehensive multidisciplinary management and emerging Therapies /
LDR:02507nmm a2200325 a 4500 001 552202
003 DE-He213
005 20190521120405.0
006 m d
007 cr nn 008maaau
008 191105s2019 gw s 0 eng d
020 $a 9783319969893$q(electronic bk.)
020 $a 9783319969886$q(paper)
024 7 $a 10.1007/978-3-319-96989-3 $2 doi
035 $a 978-3-319-96989-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.K5 $b R374 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99461 $2 23
090 $a RC280.K5 $b R221 2019
245 0 0 $a Rare kidney tumors $h [electronic resource] : $b comprehensive multidisciplinary management and emerging Therapies / $c edited by Gabriel G. Malouf, Nizar M. Tannir.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a ix, 128 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- Hereditary RCC Syndromes -- Wilms Tumor -- Renal Cell Carcinomas in Children -- Chromophobe Renal Cell Carcinomas -- Papillary Renal Cell Carcinoma -- Renal Medullary Carcinomas -- Collecting Duct Carcinomas -- Translocation Renal Cell Carcinomas -- Angiomylipoma -- Sarcomatoid and Rhabdoid Renal Cell Carcinoma -- Conclusion.
520 $a This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist. Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors.
650 0 $a Kidneys $x Cancer. $3 560142
650 0 $a Kidneys $x Diseases. $3 318100
650 1 4 $a Oncology. $3 195181
650 2 4 $a Urology. $3 318461
650 2 4 $a Pediatrics. $3 274247
700 1 $a Malouf, Gabriel G. $3 832736
700 1 $a Tannir, Nizar M. $3 832737
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-319-96989-3
950 $a Medicine (Springer-11650)